A Study of RGLS4326 in Patients With Autosomal Dominant Polycystic Kidney Disease

Clinical trial NCT04536688 · COMPLETED

Trial details

NCT number: NCT04536688
Sponsor: Regulus Therapeutics Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Polycystic Kidney Disease, Autosomal Dominant

Start date: 2020-10-13
Primary completion: 2021-11-12
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.